Program: Scientific Program
Session: JOINT SESSION: Molecular Characterization of Lymphomas in Children, Adolescents, and Young Adults
Hematology Disease Topics & Pathways:
Research, Clinical trials, Translational Research
Session: JOINT SESSION: Molecular Characterization of Lymphomas in Children, Adolescents, and Young Adults
Hematology Disease Topics & Pathways:
Research, Clinical trials, Translational Research
Saturday, December 7, 2024, 4:00 PM-5:35 PM
Disclosures: Chapuy: AbbVie, Ars tempi, Astra Zeneca, BMS, Incyte, Janssen, Gilead, KML, Roche, Sobi, Ono: Honoraria; Sobi, Roche: Other: travel support ; AbbVie, Bristol Myers Squibb, Incyte, Janssen, Roche, and Sobi: Consultancy.
See more of: JOINT SESSION: Molecular Characterization of Lymphomas in Children, Adolescents, and Young Adults
See more of: Scientific Program
See more of: Scientific Program
<< Previous Presentation
|
Next Presentation